Arkolith/Insider Trading/GNCA/Form 4

Clark William D

President and CEO, DirectorGENOCEA BIOSCIENCES, INC. (GNCA) · full profile →Form 4 · filed Mar 17, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13K
Net Open-Market Flow
-$13K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2022Sell(S)11K$1.10$13K373K
Mar 15, 2022Grant(A)150K—$0385K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 15, 2022Grant(A)450K—$0450K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001457612-22-000026) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML